• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
PublishGo to App
    Quantisnow Logo

    © 2026 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI superconnector for talent & startupsNEWLLM Arena
    Legal
    Terms of usePrivacy policyCookie policy

    SEC Form SD filed by Stryker Corporation

    5/22/26 10:27:54 AM ET
    $SYK
    Medical/Dental Instruments
    Health Care
    Get the next $SYK alert in real time by email
    SD 1 formsd05222026conflictmine.htm SD Document


    UNITED STATES
    SECURITIES AND EXCHANGE COMMISSION
    Washington, D.C. 20549


    FORM SD
    SPECIALIZED DISCLOSURE REPORT

    strykerlogoa70.jpg
    STRYKER CORPORATION
    (Exact name of registrant as specified in its charter)
    Michigan001-1314938-1239739
    (State of incorporation)(Commission File Number)(I.R.S. Employer Identification No.)
    1941 Stryker Way Portage, Michigan49002
    (Address of principal executive offices)(Zip Code)
    Viju S. Menon, Group President, Global Quality and Operations; (269) 385-2600
    (Name and telephone number, including area code, of the person to contact in connection with this report)




    Check the appropriate box to indicate the rule pursuant to which this form is being filed, and provide the period to which the information in this form applies:

    XRule 13p-1 under the Securities Exchange Act (17 CFR 240.13p-1) for the reporting period from January 1 to December 31, 2025
        























    Section 1 - Conflict Minerals Disclosure
    ITEM 1.01 and 1.02Conflict Minerals Disclosure and Report, Exhibit
    A copy of Stryker Corporation’s Conflict Minerals Report is provided as Exhibit 1.01 hereto and is publicly available at www.stryker.com. The content of any website referred to in this Form SD is included for general information only and is not incorporated by reference in this Form SD.

    Section 2 - Exhibits
    ITEM 2.01Exhibits
    The following exhibit is filed as part of this report:
    Exhibit 1.01
    Conflict Minerals Report as required by Items 1.01 and 1.02 of this Form

    SIGNATURES
    Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the duly authorized undersigned.
    STRYKER CORPORATION
    (Registrant)
    Date:May 22, 2026/s/ VIJU S. MENON
    Viju S. Menon
    Group President, Global Quality and Operations



    Get the next $SYK alert in real time by email

    Crush Q1 2026 with the Best AI Superconnector

    Stay ahead of the competition with Standout.work - your AI-powered talent-to-startup matching platform.

    AI-Powered Inbox
    Context-aware email replies
    Strategic Decision Support
    Get Started with Standout.work

    Recent Analyst Ratings for
    $SYK

    DatePrice TargetRatingAnalyst
    7/9/2026$369.00Outperform
    BMO Capital Markets
    4/13/2026$410.00Outperform
    Leerink Partners
    2/20/2026Outperform
    William Blair
    1/27/2026$387.00Hold
    TD Cowen
    1/6/2026$418.00Mkt Perform → Outperform
    Raymond James
    12/19/2025$440.00Mkt Perform → Mkt Outperform
    Citizens JMP
    9/18/2025$420.00Neutral
    Rothschild & Co Redburn
    2/26/2025$450.00Buy
    Citigroup
    More analyst ratings

    $SYK
    SEC Filings

    View All

    Stryker Corporation filed SEC Form 8-K: Other Events, Financial Statements and Exhibits

    8-K - STRYKER CORP (0000310764) (Filer)

    6/26/26 3:45:42 PM ET
    $SYK
    Medical/Dental Instruments
    Health Care

    SEC Form SD filed by Stryker Corporation

    SD - STRYKER CORP (0000310764) (Filer)

    5/22/26 10:27:54 AM ET
    $SYK
    Medical/Dental Instruments
    Health Care

    SEC Form 8-K filed by Stryker Corporation

    8-K - STRYKER CORP (0000310764) (Filer)

    5/20/26 4:21:47 PM ET
    $SYK
    Medical/Dental Instruments
    Health Care

    $SYK
    Press Releases

    Fastest customizable press release news feed in the world

    View All

    Stryker expands Mako robotics portfolio with full market release of Mako RPS

    New handheld robotic technology expands the Mako platform and brings Mako robotic-assisted knee replacement to a new segment of the orthopaedic marketStryker announced the U.S. commercial launch of Mako RPS (Robotic Power System) for total knee replacement procedures.The launch introduces Mako Handheld Robotics, expanding the Mako portfolio beyond robotic-arm assisted surgery.Mako RPS combines robotic execution, intraoperative planning and a familiar handheld power tool workflow.PORTAGE, Mich., July 16, 2026 /PRNewswire/ -- Stryker (NYSE:SYK), a global leader in medical technologies, announced today the U.S. commercial launch of Mako RPS® (Robotic Power System) for total knee replacement pro

    7/16/26 9:05:00 AM ET
    $SYK
    Medical/Dental Instruments
    Health Care

    Stryker to announce second quarter 2026 financial results

    Portage, Michigan, July 01, 2026 (GLOBE NEWSWIRE) -- Stryker (NYSE:SYK) will host a webcast at 4:30 p.m. (Eastern time) on Thursday, July 30, 2026, to discuss its second quarter 2026 financial results.  The live webcast can be accessed at Stryker - Events & Presentations.  An archive of the webcast will also be available at Stryker’s website beginning approximately two hours after the live call ends. An accompanying press release that includes summary financial information for the second quarter will be issued at approximately 4:05 p.m. (Eastern time) and available at Stryker - Press Releases on the day of the webcast. About Stryker Stryker is a global leader in medical technologies and

    7/1/26 8:00:00 AM ET
    $SYK
    Medical/Dental Instruments
    Health Care

    Stryker partners with professional golfer Shane Lowry to spotlight the caregiver journey in joint replacement

    PORTAGE, Mich., June 24, 2026 /PRNewswire/ -- Stryker (NYSE:SYK), a global leader in medical technologies, today announced a new partnership with Major Champion and globally recognized golfer Shane Lowry at the Travelers Championship in Cromwell, Connecticut, naming him a sponsored brand ambassador for its Joint Replacement division. Through this collaboration, Lowry will share a deeply personal story, highlighting the critical role caregivers play in supporting loved ones through joint pain, surgery and recovery. As a caregiver to his father, Brendan, a former Gaelic football p

    6/24/26 8:03:00 AM ET
    $SYK
    Medical/Dental Instruments
    Health Care

    $SYK
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    View All

    $SYK
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    View All

    President and COO Stiles Spencer S gifted 1,607 shares, decreasing direct ownership by 2% to 76,027 units (SEC Form 4)

    4 - STRYKER CORP (0000310764) (Issuer)

    6/2/26 4:24:03 PM ET
    $SYK
    Medical/Dental Instruments
    Health Care

    VP, Chief Legal Officer Fletcher Robert S sold $1,394,409 worth of shares (4,544 units at $306.87) as part of a pre-agreed trading plan, decreasing direct ownership by 30% to 10,582 units (SEC Form 4)

    4 - STRYKER CORP (0000310764) (Issuer)

    5/29/26 4:59:21 PM ET
    $SYK
    Medical/Dental Instruments
    Health Care

    Director Stryker Ronda E sold $96,792,669 worth of shares (310,000 units at $312.23) (SEC Form 4)

    4 - STRYKER CORP (0000310764) (Issuer)

    5/28/26 5:22:36 PM ET
    $SYK
    Medical/Dental Instruments
    Health Care

    BMO Capital Markets initiated coverage on Stryker with a new price target

    BMO Capital Markets initiated coverage of Stryker with a rating of Outperform and set a new price target of $369.00

    7/9/26 9:30:57 AM ET
    $SYK
    Medical/Dental Instruments
    Health Care

    Leerink Partners initiated coverage on Stryker with a new price target

    Leerink Partners initiated coverage of Stryker with a rating of Outperform and set a new price target of $410.00

    4/13/26 9:01:23 AM ET
    $SYK
    Medical/Dental Instruments
    Health Care

    William Blair initiated coverage on Stryker

    William Blair initiated coverage of Stryker with a rating of Outperform

    2/20/26 8:25:36 AM ET
    $SYK
    Medical/Dental Instruments
    Health Care

    $SYK
    Leadership Updates

    Live Leadership Updates

    View All

    GE HealthCare appoints medtech leader Kevin Lobo to Board of Directors

    GE HealthCare (NASDAQ:GEHC) announced today the appointment of Kevin A. Lobo, Chair and Chief Executive Officer of Stryker Corporation (NYSE:SYK), to its Board of Directors effective March 13. Mr. Lobo brings more than 25 years of medical technology, operational, and financial leadership experience. His clinical expertise and track record of driving innovation and scaling global businesses make him well qualified to contribute to GE HealthCare's strategic priorities. "Kevin is a seasoned healthcare executive with a deep understanding of the medical technology landscape. His knowledge and insight will further strengthen our Board as we continue to build a more personalized, connected and s

    3/17/26 9:00:00 AM ET
    $GEHC
    $SYK
    Medical Electronics
    Health Care
    Medical/Dental Instruments

    Stryker showcases continued innovation across orthopaedics at AAOS 2026 Annual Meeting

    Evolving technologies and offerings reinforce commitment to shaping the future of orthopaedic care PORTAGE, Mich., March 3, 2026 /PRNewswire/ -- Stryker (NYSE:SYK), a global leader in medical technologies, showcases its commitment to innovation across orthopaedic specialties with the introduction of the newest additions to the Triathlon® Total Knee System, the expanded Mako SmartRobotics™ portfolio and continued evolution of the power tool portfolio at the American Academy of Orthopaedic Surgeons' (AAOS) 2026 Annual Meeting in New Orleans. Triathlon Gold: Building on the legacy

    3/3/26 8:00:00 AM ET
    $SYK
    Medical/Dental Instruments
    Health Care

    Stryker showcases next generation of Mako SmartRobotics™ at AAOS 2025 Annual Meeting

    Latest technology offers more applications and innovation across more specialties MAHWAH, N.J., March 11, 2025 /PRNewswire/ -- Stryker (NYSE:SYK), a global leader in medical technologies, showcases the latest advancements in Mako SmartRobotics™ across hip, knee, spine and shoulder procedures at the American Academy of Orthopaedic Surgeons' (AAOS) 2025 Annual Meeting in San Diego. With over 1.5 million Mako procedures performed globally across 45 countries, Mako is a market-leading technology in orthopaedics. With the introduction of Mako Total Hip with Advanced Primary and Rev

    3/11/25 8:03:00 AM ET
    $SYK
    Medical/Dental Instruments
    Health Care

    $SYK
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    View All

    SEC Form SC 13G/A filed by Stryker Corporation (Amendment)

    SC 13G/A - STRYKER CORP (0000310764) (Subject)

    2/12/24 10:18:54 AM ET
    $SYK
    Medical/Dental Instruments
    Health Care

    SEC Form SC 13G/A filed by Stryker Corporation (Amendment)

    SC 13G/A - STRYKER CORP (0000310764) (Subject)

    2/14/23 12:37:55 PM ET
    $SYK
    Medical/Dental Instruments
    Health Care

    SEC Form SC 13G/A filed by Stryker Corporation (Amendment)

    SC 13G/A - STRYKER CORP (0000310764) (Subject)

    2/10/23 9:18:16 AM ET
    $SYK
    Medical/Dental Instruments
    Health Care

    $SYK
    Financials

    Live finance-specific insights

    View All

    Stryker completes acquisition of Amplitude Vascular Systems to add next-generation IVL technology to peripheral vascular portfolio

    Portage, Michigan, May 07, 2026 (GLOBE NEWSWIRE) -- Stryker (NYSE:SYK announced that it has completed the acquisition of Amplitude Vascular Systems, Inc. (AVS), a privately held medical technology company developing a next-generation intravascular lithotripsy (IVL) platform designed to treat complex peripheral arterial disease. "This acquisition is a significant milestone in expanding our peripheral vascular portfolio and enhancing our ability to address challenging arterial disease," said Kevin Lobo, Chair and CEO, Stryker. "By integrating AVS's innovative CO₂-generated pressure wave technology with Stryker's scale and resources, we are well-positioned to deliver solutions that support p

    5/7/26 4:05:00 PM ET
    $SYK
    Medical/Dental Instruments
    Health Care

    Stryker declares an $0.88 per share quarterly dividend

    Portage, Michigan, May 07, 2026 (GLOBE NEWSWIRE) -- Stryker (NYSE:SYK) announced that its Board of Directors has declared a quarterly dividend of $0.88 per share payable July 31, 2026, to shareholders of record at the close of business on June 30, 2026, representing an increase of 4.8% versus the prior year and unchanged from the previous quarter.  About Stryker Stryker is a global leader in medical technologies and, together with our customers, we are driven to make healthcare better. We offer innovative products and services in MedSurg, Neurotechnology and Orthopaedics that help improve patient and healthcare outcomes. Alongside our customers around the world, we impact more than 150 m

    5/7/26 8:00:00 AM ET
    $SYK
    Medical/Dental Instruments
    Health Care

    Stryker reports first quarter 2026 operating results

    Portage, Michigan, April 30, 2026 (GLOBE NEWSWIRE) -- Stryker (NYSE:SYK) reported operating results for the first quarter of 2026: First Quarter Results Reported net sales increased 2.6% to $6.0 billionOrganic net sales increased 2.4%Reported operating income margin of 15.5%Adjusted operating income margin(1) contracted 180 bps to 21.1%Reported EPS increased 14.2% to $1.93 Adjusted EPS(1) decreased 8.5% to $2.60  First Quarter Net Sales Growth Overview Reported Foreign Currency Exchange Constant Currency Acquisitions / Divestitures OrganicMedSurg and Neurotechnology        5.0        %         1.4        %         3.6        %         2.7        %         0.9        %Orthopaedics        

    4/30/26 4:05:00 PM ET
    $SYK
    Medical/Dental Instruments
    Health Care